e-Table 3 –
Multivariable analysis of IGF-1 and lung function measures (as z-scores)
All participants (n=212,462) | Women (n=113,769) | Men (n=98,693) | |
---|---|---|---|
IGF-1 quartile | β (95% Confidence Interval) | ||
All Participants | |||
FEV1 z-score | 0.020 (0.016, 0.024)* | 0.021 (0.015, 0.026)* | 0.027 (0.021, 0.034)* |
FVC z-score | 0.020 (0.017, 0.024)* | 0.022 (0.017, 0.027)* | 0.028 (0.022, 0.034)* |
FEV1/FVC z-score | 0.002 (−0.001, 0.006) | −0.002 (−0.006, 0.002) | 0.001 (−0.004, 0.006) |
Participants without asthma | n=188,123 | n=100,031 | n=88,092 |
FEV1 z-score | 0.020 (0.016, 0.024)* | 0.020 (0.014, 0.026)* | 0.025 (0.018, 0.031)* |
FVC z-score | 0.020 (0.016, 0.024)* | 0.022 (0.016, 0.027)* | 0.026 (0.020, 0.032)* |
FEV1/FVC z-score | 0.003 (−0.004, 0.006) | −0.004 (−0.006, 0.002) | −0.001 (−0.006, 0.004) |
Participants with asthma | n=24,339 | n=13,738 | n=10,601 |
FEV1 z-score | 0.023 (0.010, 0.036)* | 0.025 (0.008, 0.042)* | 0.049 (0.028, 0.070)* |
FVC z-score | 0.027 (0.015, 0.038)* | 0.025 (0.010, 0.040)* | 0.046 (0.028, 0.064)* |
FEV1/FVC z-score | 0.001 (−0.010, 0.012) | 0.003 (−0.010, 0.017) | 0.017 (−0.001, 0.036) |
Abbreviation: IGF-1, insulin-growth like factor 1. FEV1, forced expiratory volume in one second; FVC, forced vital capacity.
All models adjusted for asthma status (in all participants), annual household income, body mass index, smoking status, pack-years of cigarette smoking, the season and the time of the day when the examination was performed, and serum level of glycated hemoglobin A1c, and C-reactive protein.
P <0.01